|
|
Clinical drug resistance of Enterobacteriaceae producing ESBLs bacteria |
LI Juan1 DENG Qiu-lian2▲ LONG Yan2 HUANG Yu-jun2 SHANG Yan-yan1 YANG Li-na1 |
1.Clinical Laboratory,Affiliated Tumor Hospital of Guangzhou Medical University,Guangdong Province,Guangzhou 510095,China;
2.Clinical Laboratory,Women and Children Medical Center of Guangzhou City,Guangdong Province, Guangzhou 510623,China |
|
|
Abstract ObjectiveTo study the clinical drug resistance of Enterobacteriaceae producing ESBLs bacteria.Methods4265 strains of Enterobacteriaceae pathogenic bacteria in our hospital from July 2014 to September 2016 were selected, biological Meiliai analyzer was used for identification,after identification of ESBLs producing strain,drug sensitivity test was carried out to analyze the drug resistance of ESBLs producing bacteria in clinical antibiotics.ResultsAmong 4265 strains of Enterobacteriaceae,the ESBLs producing bacteria were mainly distributed in Proteus mirabilis,Klebsiella, Klebsiella pneumoniae and Escherichia coli.There were 2415 strains of ESBLs bacteria,the detection rate was 56.62%. The detection rate of ESBLs bacteria in pus,secretion,urine and bile in human body were higher.There was significant difference in the detection rate of ESBLs bacteria in different samples(P<0.05).ESBLs producing bacteria were resistant to some antibiotics,most antibiotics were ineffective in producing ESBLs bacteria,while Imipenem was sensitive to ESBLs producing strains.ConclusionAmong the pathogenic bacteria of Enterobacteriaceae,ESBLs bacteria are the main bacteria,and most of antibiotics are ineffective,Imipenem is the last line of defense against ESBLs bacteria.It is suggested that antibiotics should be monitored before the clinical use of antimicrobial agents,and rational use of drugs according to the doctor′s advice is the main means to control and reduce the production of ESBLs bacteria.
|
|
|
|
|
[1] |
张晓兵,府伟灵,廖扬,等.临床产ESBLs细菌的耐药特征和基因分型的研究[J].中华医院感染学杂志,2015,15(4):386-389.
|
[2] |
司红彬,宋剑武,王鹏霞,等.救必应中药血清与抗菌药联合对产ESBLs细菌抑菌效果的研究[J].中国畜牧兽医,2015,42(4):1009-1014.
|
[3] |
宋剑武,陈秋莹,陆云,等.救必应不同提取物与西药联合对产ESBLs细菌作用研究[J].中国畜牧兽医,2014,41(4):248-251.
|
[4] |
张永标,张扣兴,唐英春,等.13种抗生素对产AmpC酶或同时产ESBLs细菌的体外抗菌活性[J].中国抗生素杂志,2013,28(9):541-544,551.
|
[5] |
马莹.产超广谱β内酰胺酶肠杆菌科细菌对磷霉素的耐药机制研究[D].上海:复旦大学,2013.
|
[6] |
刘琼,陈雪初,余宇奇,等.肠杆菌科产ESBLs细菌的临床分布和耐药分析[J].实用预防医学,2012,19(1):116-118.
|
[7] |
娄小燕,金伟峰,朱莉莉,等.某三甲医院血培养病原菌分布及耐药分析[J].国际检验医学杂志,2016,37(23):3263-3265,3268.
|
[8] |
林海波,张国成,许东亮,等.儿童呼吸道感染产超广谱β-内酰胺酶细菌的耐药表型及耐药基因研究[J].临床儿科杂志,2013,31(2):129-133.
|
[9] |
路娟,陈淑兰,董娟,等.1909株革兰氏阴性杆菌中产ESBLs细菌分离率及耐药性[J].哈尔滨医科大学学报,2012,36(1):78-79.
|
[10] |
邢金芳,贾莉婷,张霞,等.儿童呼吸道感染产超广谱β-内酰胺酶菌的耐药表型及耐药基因研究[J].中华医院感染学杂志,2014,14(19):4684-4686.
|
[11] |
肖倩.产 ESBLs细菌的研究进展[J].广西医学,2002,7(5):673-676.
|
[12] |
陈茶,黄彬.大肠埃希菌、肺炎克雷伯菌超广谱β-内酰胺酶的检测及耐药特性[J].中华医院感染学杂志,2012,12(1):73-74.
|
[13] |
朱瑞琪,张蕴莉,张淑芹,等.2011-2013年某综合性医院产ESBLs细菌的分布及耐药动态监测[J].现代预防医学,2015,42(18):3450-3453.
|
[14] |
赵德军,付维婵,武静,等.老年肺部感染产ESBLs细菌调查及耐药性分析[J].中国老年学杂志,2012,30(6):835-836.
|
[15] |
管希周,刘又宁,王睿,等.临床产ESBLs细菌耐药特性及其基因分型的研究[J].药物与临床,2013,16(6):15-19.
|
[16] |
龚光明,李桃,张晓芳,等.产超广谱β-内酰胺酶肠杆菌科细菌的临床分布与耐药性分析[J].中华医院感染学杂志,2016,26(1):13-15.
|
[17] |
解春宝,肖代雯,杨永长,等.多药耐药肠杆菌科细菌超广谱β-内酰胺酶基因分析[J].中华医院感染学杂志,2015,25(5):992-994.
|
[18] |
唐景云,秦晓林.ESBLs在大肠埃希菌、肺炎克雷伯菌和阴沟肠杆菌中的检出率及耐药情况比较[J].中国医药科学,2016,6(3):175-178.
|
[19] |
张祎博,查庆华,倪语星,等.磷霉素氨丁三醇对尿标本中肠杆菌科细菌体外抗菌活性研究[J].中国感染与化疗杂志,2014,14(2):153-156.
|
[20] |
王卓,王雨新,陈强,等.产ESBLs肠杆菌科细菌的检测及耐药性[J].中国微生态学杂志,2016,28(5):564-566,569.
|
|
|
|